✦ LIBER ✦

Inactivation of MMAC1 in bladder transitional-cell carcinoma cell lines and specimens

✍ Scribed by Juehui Liu; David C. Babaian; Monica Liebert; Peter A. Steck; Jacob Kagan

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 178 KB
Volume: 29
Category: Article
ISSN: 0899-1987
DOI: 10.1002/1098-2744(200011)29:3<143::aid-mc3>3.0.co;2-a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PTEN/MMAC1/TEP1 mutations in human prima

PTEN/MMAC1/TEP1 mutations in human primary renal-cell carcinomas and renal carcinoma cell lines

✍ Kei-ichi Kondo; Masahiro Yao; Kazuki Kobayashi; Shinsuke Ota; Minoru Yoshida; Sh 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 188 KB 👁 2 views

Detailed marker chromosome analysis in c

Detailed marker chromosome analysis in cell line U-BLC1, established from transitional-cell carcinoma of the bladder

✍ Jochen Bruch; Gudrun Wöhr; Silke Brüderlein; Gotthold Barbi; Hubertus Wolter; Ch 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 301 KB 👁 2 views

A permanent cell line, U-BLC1, was established from a primary transitional-cell carcinoma, TCC, of the urinary bladder. Karyotype analysis showed the line to be highly aberrant, with a near-triploid chromosome number of 68 to 73. Comparative genomic hybridization revealed some distinct differences b

Galectin-1 and galectin-3 expression in

Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas

✍ Luca Cindolo; Giovanna Benvenuto; Paola Salvatore; Raffaela Pero; Gaetano Salvat 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 133 KB 👁 1 views

Galectin-1 and galectin-3 are galactoside-binding proteins involved in different steps of tumor progression and potential targets for therapy. We have investigated the expression of these galectins in 38 human bladder transitional-cell carcinomas of different histological grade and clinical stage an

Intraarterial cisplatin infusion in the

Intraarterial cisplatin infusion in the management of transitional cell carcinoma of the bladder

✍ Stephen C. Jacobs; David S. Menashe; Mark W. Mewissen; Elliott O. Lipchik 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB 👁 2 views

Patients with superficial transitional c

Patients with superficial transitional cell carcinoma of the bladder and their smoking status

✍ Joseph A. Smith Jr. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 33 KB 👁 1 views

Mutational inactivation of aminoacylase-

Mutational inactivation of aminoacylase-1 in a small cell lung cancer cell line

✍ Robert M. Cook; Wilbur A. Franklin; Mark D. Moore; Bruce E. Johnson; York E. Mil 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

Small cell lung cancer (SCLC) cell lines and tumors invariably exhibit loss of heterozygosity (LOH) or, in rare cases, homozygous deletions involving part or all of chromosome arm 3p, suggesting the presence of 1 or more tumor-suppressor genes in this region. The gene encoding aminoacylase-1 (ACY1)